Immunoexpression of HSPA9 and CUL2 in prostatic tissue and adenocarcinoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34717191/
CUL2 plays a crucial role in proteolysis by preserving the balance between normal growth and uncontrolled proliferation. HSPA9 safeguards the integrity of protein interactions and supports cellular homeostasis. In carcinomas,...
Dose-based radiomic analysis (dosiomics) for intensity-modulated radiotherapy in patients with prostate cancer: Correlation between planned dose distribution and biochemical failure - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34706278/
The dosiomic feature extracted from the CTV was significantly correlated with BCR in patients with prostate cancer, and the dosiomics model outperformed the model with conventional dose indices. Hence, new...
Cleveland Clinic study links gut microbiome and aggressive prostate cancer: Researchers uncover how diet, lifestyle modifications may lower risk of lethal disease
Source : https://www.sciencedaily.com/releases/2021/10/211028120417.htm
Researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. While more research will...
Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments? - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34707693/
Biochemical recurrence is an evolving space in prostate cancer, with increasing multidisciplinary involvement. Androgen deprivation therapy has shown proof of its value in complementing salvage radiotherapy in high-risk biochemical relapsing...
Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34712607/
Currently available evidence demonstrated that the efficacy and safety of CIRT and PBT for prostate cancer were similar, and they may significantly improve the OS, LCR, and reduce the incidence...